Stocktoria
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 300760.SZ
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 3.27% (safety: stretched). FY2025 revenue was CN¥33.3B at a 24.4% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 46 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.267 |
| Retained earnings / assets | 0.509 |
| EBIT / assets | 0.168 |
| Equity / liabilities | 2.343 |
FAQ
Is 300760.SZ financially healthy?
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does 300760.SZ pay a dividend, and is it safe?
Yes. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. pays a dividend yielding about 3.27% with a 69.0% payout ratio, rated “stretched” for safety.
How profitable is 300760.SZ?
In FY2025, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. had a net margin of 24.4% and a return on equity of 21.4%.
Source: company filings via Yahoo Finance · CN · as of 2025-12-31. Figures in CNY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.